Sunshine Biopharma, Inc. (SBFM) | Bitcoin Treasury Stock

Sunshine Biopharma, Inc.
SBFM
$0.9 (6.77%)
Last update 07:56 PM UTC · Sep 18 · NASDAQ
Sunshine Biopharma, Inc.
SBFM
Bitcoin Treasury Stock · NASDAQ · Fort Lauderdale, CA
$0.9 (6.77%)
Last update 07:56 PM UTC · Sep 18, 2026
Market Cap
$2.14M
Enterprise Value
-$11.61M
Next Earnings
Nov 12, 2026

Market Overview

Market Cap
$2,135,965
Shares Outstanding
2,378,316
50-Day Moving Average
$1.32
200-Day Moving Average
$7.42
Average Volume (20 Days)
645,441
Beta (5Y)
1.31

Price History

Date OPEN HIGH LOW CLOSE VWAP VOLUME %CHG $CHG

Sunshine Biopharma, Inc. Company Overview

Sunshine Biopharma, Inc. (NASDAQ: SBFM) is a pharmaceutical and nutritional-supplement company focused on the research and development of anticancer drugs and anti-coronavirus treatments. The company is developing Adva-27a (a podophyllotoxin-derivative anticancer drug targeting leukemia, lymphoma, and various solid tumors, including multidrug-resistant cancer cells) and SBFM-PL4 (an anti-coronavirus compound), alongside selling Essential 9 nutritional supplements. Sunshine Biopharma holds Bitcoin on its corporate balance sheet as part of a digital asset treasury strategy.

Sunshine Biopharma, Inc. website url Visit Website Sunshine Biopharma, Inc. twitter url
Stock Exchange NASDAQ
IPO Date 2022-02-15
Number of Employees 50
Headquarters Fort Lauderdale, Florida, CA

Key Executives

Steve N. Slilaty

Chairman, President & Chief Executive Officer
Steve N. Slilaty linkedin Steve N. Slilaty twitter

Camille Sebaaly

CFO, Secretary & Director
Camille Sebaaly linkedin Camille Sebaaly twitter

Robert G. Ferreira

President of Sunshine Bio Investments Inc
Robert G. Ferreira linkedin Robert G. Ferreira twitter

Malek Chamoun

Chief Development Officer
Malek Chamoun linkedin Malek Chamoun twitter

Michel Roy

Chief Commercial Officer
Michel Roy linkedin Michel Roy twitter

Featured Posts

View all articles

Press Releases

No press releases found.

SEC Filings

Form Type Filed Accepted Source

SBFM Frequently Asked Questions

The next earnings report date for Sunshine Biopharma, Inc. (SBFM) is scheduled for November 12, 2026. Stay up to date with ’s financial results and key announcements by visiting our Earnings Tracker or by subscribing to earnings alerts. Here we also provide SBFM earnings call summaries and transcripts.

The current stock price of Sunshine Biopharma, Inc. (SBFM) is $0.9 as of 07:56 PM UTC · Sep 18, 2026 . For live stock updates and company rankings, view our Bitcoin mining stocks by market cap table.

The latest news for Sunshine Biopharma, Inc. (SBFM) includes Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies published on September 16, 2026 . For more details and ongoing updates, visit the SBFM news section.